Zur Kurzanzeige

2024-02-01Zeitschriftenartikel
Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023
dc.contributor.authorCai, Wei
dc.contributor.authorKöndgen, Sophie
dc.contributor.authorTolksdorf, Kristin
dc.contributor.authorDürrwald, Ralf
dc.contributor.authorSchuler, Ekkehard
dc.contributor.authorBiere, Barbara
dc.contributor.authorSchweiger, Brunhilde
dc.contributor.authorGoerlitz, Luise
dc.contributor.authorHaas, Walter
dc.contributor.authorWolff, Thorsten
dc.contributor.authorBuda, Silke
dc.contributor.authorReiche, Janine
dc.date.accessioned2026-03-25T13:00:28Z
dc.date.available2026-03-25T13:00:28Z
dc.date.issued2024-02-01none
dc.identifier.other10.2807/1560-7917.ES.2024.29.13.2300465
dc.identifier.urihttp://edoc.rki.de/176904/13589
dc.description.abstractBackground: Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic affected respiratory syncytial virus (RSV) circulation worldwide. Aim: To describe, for children aged < 5 years, the 2021 and 2022/23 RSV seasons in Germany. Methods: Through data and 16,754 specimens from outpatient sentinel surveillance, we investigated RSV seasonality, circulating lineages, and affected children’s age distributions in 2021 and 2022/23. Available information about disease severity from hospital surveillance was analysed for patients with RSV-specific diagnosis codes (n = 13,104). Differences between RSV seasons were assessed by chi-squared test and age distributions trends by Mann–Kendall test. Results: RSV seasonality was irregular in 2021 (weeks 35–50) and 2022/23 (weeks 41–3) compared to pre-COVID-19 2011/12–2019/20 seasons (median weeks 51–12). RSV positivity rates (RSV-PR) were higher in 2021 (40% (522/1,291); p < 0.001) and 2022/23 (30% (299/990); p = 0.005) than in prior seasons (26% (1,430/5,511)). Known globally circulating RSV-A (lineages GA2.3.5 and GA2.3.6b) and RSV-B (lineage GB5.0.5a) strains, respectively, dominated in 2021 and 2022/23. In 2021, RSV-PRs were similar in 1 – < 2, 2 – < 3, 3 – < 4, and 4 – < 5-year-olds. RSV hospitalisation incidence in 2021 (1,114/100,000, p < 0.001) and in 2022/23 (1,034/100,000, p < 0.001) was approximately double that of previous seasons’ average (2014/15–2019/20: 584/100,000). In 2022/23, proportions of RSV patients admitted to intensive care units rose (8.5% (206/2,413)) relative to pre-COVID-19 seasons (6.8% (551/8,114); p = 0.004), as did those needing ventilator support (6.1% (146/2,413) vs 3.8% (310/8,114); p < 0.001). Conclusions: High RSV-infection risk in 2–4-year-olds in 2021 and increased disease severity in 2022/23 possibly result from lower baseline population immunity, after NPIs diminished exposure to RSV.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subjectacute respiratory infectioneng
dc.subjectchildreneng
dc.subjectdisease severityeng
dc.subjectgenotypeeng
dc.subjectlineageeng
dc.subjectphylogenyeng
dc.subjectrespiratory syncytial viruseng
dc.subjectsurveillanceeng
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleAtypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023none
dc.typearticle
dc.identifier.urnurn:nbn:de:0257-176904/13589-7
dc.type.versionpublishedVersionnone
local.edoc.container-titleEurosurveillance - Europe's journal on infectious disease surveillance, epidemiology, prevention and controlnone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-publisher-nameEuropean Centre for Disease Prevention and Controlnone
local.edoc.container-reportyear2024none
local.edoc.container-firstpage1none
local.edoc.container-lastpage13none
dc.description.versionPeer Reviewednone

Zur Kurzanzeige